Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing phase 4 study of Jinlida granule plus metformin in type 2 diabetes mellitus
ChiCTR-TRC-13003159Phase 4Completed
- Sponsor
- Guang'anmen Hospital
- Start
- Mar 2013
- Countries
- 1
01
Overview
Phase 4, open-label trial of jinlida in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Guang'anmen Hospital. Primary endpoint: Glycated hemoglobin. Started Mar 2013; status: completed.
02
Drugs
jinlida
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-TRC-13003159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-13003159.